BPC-157 and growth hormone receptors in tendon fibroblasts · 2014
Tendon fibroblast experiments examined growth-hormone receptor expression and responses to growth signals. Cell findings do not demonstrate tendon healing in patients.
Read source
FSD BIO LABS · Product artwork
A 10 mg blend of BPC-157 and TB-500 for laboratory research into tissue-related peptide signalling.
20 vials available
Full prepaid by UPI includes free delivery. COD requires 5% advance and a 1.5% delivery fee. Payment details
See delivery information and return conditions before ordering. Your final total is shown at checkout.
COA not yet available for this strength
BPC-157 5 mg + TB-500 5 mg; 10 mg total. Confirm the exact identity and sequence of the TB-500 component against the available batch documentation.
Not for human or veterinary administration. Listed strength is a supplied specification; see the matching batch report for measured results.
Wolverine combines 5 mg BPC-157 and 5 mg TB-500 in one vial, for a total labelled content of 10 mg. Component research includes preclinical tendon-cell studies for BPC-157 and analytical characterisation of materials sold as TB-500.
BPC-157 5 mg + TB-500 5 mg; 10 mg total. Confirm the exact identity and sequence of the TB-500 component against the available batch documentation.
These papers concern individual ingredients, not the finished blend. Each source identifies what was studied and the limits of its findings. Published research is separate from this product’s batch COA.
Tendon fibroblast experiments examined growth-hormone receptor expression and responses to growth signals. Cell findings do not demonstrate tendon healing in patients.
Read sourceAnalytical work identified an acetylated thymosin beta-4 fragment in material sold as TB-500. This is an identity study, not a clinical efficacy trial of the full-length peptide.
Read sourceWOLVERINE is currently listed in 5 mg + 5 mg. Select a strength above to see its price, product image and current stock. Listed quantities are supplied specifications, not measured batch results.
No laboratory report is currently published for this compound. Request the available documentation before relying on any batch-specific measurement. A scientific paper is not a substitute for a COA.
The supplied formula is 5 mg BPC-157 + 5 mg TB-500, totalling 10 mg. Ingredient studies do not establish the finished blend’s results. Check the original report for measured identity and quantities.